Source: PR Newswire

Press Release: Loxo Oncology : Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting

INDIANAPOLIS, May 11, 2023 /PRNewswire/ -- Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that data from its oncology portfolio will be presented at the 2023 European Hematology Association (EHA) Annual Meeting, to be held June 8 - 11, 2023, in...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Jacob S. Van Naarden's photo - CEO of Loxo Oncology

CEO

Jacob S. Van Naarden

CEO Approval Rating

82/100

Read more